We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Spit Test Detects Breast Cancer in Five Seconds

By LabMedica International staff writers
Posted on 19 Feb 2024
Print article
Image: Breast cancer could now be detected through a spit test (Photo courtesy of 123RF)
Image: Breast cancer could now be detected through a spit test (Photo courtesy of 123RF)

Breast cancer is the most commonly diagnosed cancer worldwide, with over 2.3 million new cases and approximately 685,000 deaths reported in 2020. Currently, mammography, ultrasound, MRI, and biopsies are the primary methods for diagnosing breast cancer. Despite their effectiveness, these techniques have several drawbacks, such as high costs, limited accessibility, potential inaccuracies in early detection in young women with dense breast tissue, invasiveness, and radiation exposure risks, especially for radiation-sensitive patients. Given the increasing prevalence of breast cancer in women, there is an urgent need for more innovative and efficient detection methods. Now, a saliva test that screens for breast cancer is showing promising results in experimental testing.

Developed collaboratively by researchers from the University of Florida (Gainesville, FL, USA) and National Yang Ming Chiao Tung University (Hsinchu City, Taiwan), this innovative hand-held device can detect breast cancer biomarkers using just a small saliva sample. The device operates by applying saliva to a test strip treated with specific antibodies that react to cancer biomarkers. It then sends electrical impulses to contact points on the biosensor, measuring signals that are converted into digital data, indicating the level of biomarkers present. This method provides rapid and easily interpretable results.

In trials, the device successfully differentiated between healthy breast tissue, early-stage breast cancer, and advanced breast cancer in a group of 21 women. The non-invasive test could be completed in less than a minute, including the application of a 3–5 μl saliva sample onto the strip, with each test performed 10 times within 15 milliseconds. The design of this biosensor incorporates common elements like glucose testing strips and the Arduino open-source hardware-software platform, making it user-friendly and promising for broad public use in the future.

Related Links:
University of Florida 
Yang Ming Chiao Tung University 

Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0
New
Gold Member
Rotavirus Test
Rotavirus Test - 30003 – 30073
New
Blood Culture Identification Panel
cobas ePlex BCID-GP Panel
New
Nephelometer
F-TC2015

Print article

Channels

Molecular Diagnostics

view channel
Image: Umbilical cord blood biomarkers may improve preterm infant care (Photo courtesy of Shutterstock)

Umbilical Cord Blood Test Could Identify Preterm Infants at Risk for Medical Complications

Advancements in medical technology and neonatology have significantly improved the care of prematurely born infants. However, these infants still face heightened risks for medical complications, such as... Read more

Immunology

view channel

3D Bioprinted Gastric Cancer Model Uses Patient-Derived Tissue Fragments to Predict Drug Response

Tumor heterogeneity presents a major obstacle in the development and treatment of cancer therapies, as patients' responses to the same drug can differ, and the timing of treatment significantly influences prognosis. Consequently, technologies that predict the effectiveness of anticancer treatments are essential in minimizing... Read more

Microbiology

view channel
Image: The Cytovale System isolates, images, and analyzes cells (Photo courtesy of Cytovale)

Rapid Sepsis Diagnostic Test Demonstrates Improved Patient Care and Cost Savings in Hospital Application

Sepsis is the leading cause of death and the most expensive condition treated in U.S. hospitals. The risk of death from sepsis increases by up to 8% for each hour that treatment is delayed, making early... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.